A palmitoylation-related signature predicts prognosis and immune microenvironment features in diffuse large B-cell lymphoma
The PRS captures prognostic heterogeneity and distinct immune microenvironment features in DLBCL and may provide a useful tool for risk stratification, and CEACAM3 may serve as a potential biomarker and therapeutic target in DLBCL.